CRB-15

N/A

Report date: 2024/12/18 13:39:48

Base Information

Drug NameCRB-15
Drug Alias NameDepletin
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionInterleukin-15 receptors antagonists
TargetsInterleukin-15 receptors
Therapy Area/IndicationsRejection of organ transplantationPsoriasisCrohn Disease +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBeth Israel Deaconess Medical CenterCardion
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBeth Israel Deaconess Medical CenterCardionF. Hoffmann-La Roche Ltd
Active IndicationsN/A
Inactive IndicationsRejection of organ transplantationPsoriasisCrohn Disease +[5] 

Other Information

ATC CodeN/A
Related LinksN/A